Ciclopirox topical - Acrux

Drug Profile

Ciclopirox topical - Acrux

Alternative Names: Ciclopirox MDTS

Latest Information Update: 18 Aug 2009

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Acrux
  • Class Antifungals; Pyridones; Small molecules
  • Mechanism of Action Mitosis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Onychomycosis

Most Recent Events

  • 23 May 2005 Acrux and Napa Biosciences have entered into an exclusive worldwide licensing agreement to develop and commercialise certain prescription and over-the-counter dermatology products for various skin disorders, including onychomycosis
  • 23 May 2005 Preclinical trials in Onychomycosis in USA (Topical)
  • 12 Jul 2004 Ciclopirox topical is available for licensing (
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top